Samsca Post-marketing General Drug Use-results Survey in Patients with Hyponatremia in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in Japan
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this study is to confirm the safety of tolvaptan in patients with hyponatremia in syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Japan
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Subjects with a definite diagnosis of SIADH in reference to Diagnostic and Treatment Manual of the Hypersecretion of Vasopressin (SIADH), Revised in 2018
Locations
Other Locations
Japan
Pharmacovigilance Department
RECRUITING
Osaka
Contact Information
Primary
Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
komaniwa.satoshi@otsuka.jp
+81-6-6943-7722
Time Frame
Start Date: 2021-03-29
Estimated Completion Date: 2030-01
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: Otsuka Pharmaceutical Co., Ltd.